Democratizing hedge fund level analysis tools for everyone
About |
---|
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company manufactures, trades in, and distributes medicine and medical devices; extracts and herbals; and operates laboratory. The company was formerly known as PT Indofarma (Persero) Tbk PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk is a subsidiary of PT Bio Farma.. |
Info | Profile |
---|---|
Name | Indofarma Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 6/30/2024 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Bio Farma (Persero) | 80.66 | 80.66 |
Public < 5% | 11.99 | 11.99 |
PT. Asabri (Persero) - Dapen Tni | 7.34 | 7.34 |
Others | 0.01 | 0.0 |
Classification | Latest % | Previous % |
---|---|---|
Institution | 88.01 | 88.01 |
Retail | 11.99 | 11.99 |
Individual | 0.0 | 0.0 |
Management | 0.0 | 0.0 |
Revenue Source | 2023 | 2022 |
---|---|---|
Medicine | 65.3% | 48.6% |
Medical Devices & Others | 34.7% | 51.4% |
Others | 0.0% | 0.0% |
Engineering Pharmaceutical | 0.0% | 0.0% |
Revenue Region | 2023 | 2022 |
---|---|---|
Indonesia | 100.0% | 100.0% |
Others | 0.0% | 0.0% |
Year | DPS | Yield [%] |
---|
Timeframe | Performance |
---|---|
1W % | -3.1 |
1Mo % | -45.2 |
3Mo % | -67.4 |
1Yr % | -80.0 |
Pivot | Points |
---|---|
R2 | 176.0 |
R1 | 158.0 |
S1 | 124.0 |
S2 | 108.0 |
Link download Laporan Keuangan emiten
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
INAF | -1.92 | 391 B | 2.11 T | 219 B | -140 B | -204 B |
KLBF | 22.21 | 80.63 T | 81.98 T | 32,656 B | 5,447 B | 3,610 B |
SIDO | 16.52 | 21.15 T | 20.79 T | 3,793 B | 1,623 B | 1,217 B |
TSPC | 7.07 | 11.50 T | 10.86 T | 13,554 B | 2,403 B | 1,642 B |
SOHO | 18.86 | 8.38 T | 10.43 T | 9,762 B | 600 B | 451 B |
KAEF | -10.01 | 3.92 T | 14.85 T | 10,143 B | 276 B | -411 B |